+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Opposite effects of recombinant human transforming growth factor-beta 1 on bone regeneration in vivo: effects of exclusion of periosteal cells by microporous membrane



Opposite effects of recombinant human transforming growth factor-beta 1 on bone regeneration in vivo: effects of exclusion of periosteal cells by microporous membrane



Bone 22(6): 613-620



The efficacy of local delivery of recombinant human transforming growth factor-beta 1 (rhTGF-beta 1) to promote bone regeneration, with or without cellular contribution from the periosteum, was evaluated in transosseous defects. Implantation of rhTGF-beta 1 into 5 mm in diameter "critical size defects" in the rat mandible resulted in a dose-dependent (0.1-20 micrograms/defect) bone bridging at both 12 and 24 days, independent of the type of delivery system [3% methyl cellulose gel, porous CaCO3 particles, or poly(lactide-co-glycolide) beads]. The bridging, however, never exceeded 24% at 12 days or 34% after 24 days. In contrast, when access of cells from the periosteum to the defect was prevented by means of microporous expanded polytetrafluoroethylene barrier membranes (GORE-TEX membrane), rhTGF-beta 1 caused a dose-dependent inhibition of bone regeneration. The bioactivity of the growth factor was confirmed by implantation of 5 or 10 micrograms rhTGF-beta 1 in 12 mm in diameter bicortical defects in rabbit calvaria, which resulted in complete bone healing within 28 days, whereas control defects displayed a bridging of 40%-50%. The findings support the concept, based on in vitro experiments by others, that TGF-beta 1 primarily has a proliferative effect on cells already committed to the osteoblastic lineage, but also imply that TGF-beta 1 may be inhibitory to induction of osteogenic cells in vivo.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046870427

Download citation: RISBibTeXText

PMID: 9626399


Related references

In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. Journal of Bone and Mineral Research 5(10): 1087-1096, 1990

Opposite and selective effects of epidermal growth factor and human platelet transforming growth factor-beta on the production of secreted proteins by murine 3T3 cells and human fibroblasts. Journal of Biological Chemistry 261(23): 10478-10481, 1986

Effects of recombinant basic fibroblast growth factor, insulin-like growth factor-II and transforming growth factor-beta 1 on dog dental pulp cells in vivo. Archives of Oral Biology 43(6): 431-444, 1998

Effect of bioactive ceramic and recombinant human transforming growth factor-beta (rhTGF-beta) on regeneration of parietal bone defects in rat. Journal of Long-Term Effects of Medical Implants 21(1): 71-78, 2011

Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cells. Journal of Interferon and Cytokine Research 15(12): 1075-1081, 1995

In vivo induction of bone by recombinant human transforming growth factor beta 1. Journal of Bone and Mineral Research 6(9): 961-968, 1991

Transforming growth factor beta (TGF-beta) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-beta in human bone matrix in vivo. Bone 24(6): 565-569, 1999

The effects of age on the response of rabbit periosteal osteoprogenitor cells to exogenous transforming growth factor-beta 2. Journal of Cell Science 107: 499-516, 1994

Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells. Chinese Medical Journal 110(11): 847-850, 1997

Transforming growth factor beta and fibroblast growth factor have opposite effects on the proliferation of endothelial cells. Schweizerische Medizinische Wochenschrift 116(34): 1160-1162, 1986

Interaction of transforming growth factor beta 1 with human glomerular epithelial cells in culture: opposite effects on synthesis of matrix proteins and on urokinase plasminogen activator. Journal of Molecular Medicine 74(3): 149-154, 1996

Recombinant human transforming growth factor b does not inhibit the effects of interleukin-1-beta on pancreatic islet cells. Journal of Interferon & Cytokine Research 15(12): 1075-1081, 1995

Opposite effects of osteogenic protein and transforming growth factor beta on chondrogenesis in cultured long bone rudiments. Journal of Bone and Mineral Research 9(6): 771-780, 1994

Opposite effects of transforming growth factor beta tgf beta on hiv expression in chronically versus acutely infected monocytic cells. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sa319, 1990

1,25-Dihydroxyvitamin D3, Recombinant Human Transforming Growth Factor-.Beta.1, and Recombinant Human Bone Morphogenetic Protein-2 Induce In Vitro Differentiation of Canine Osteosarcoma Cells. Journal of Veterinary Medical Science 61(6): 649-656, 1999